Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: excite (79), inspire (52), motivate (59)

Durvalumab_14day

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (14 day) Regimen • NSCLC - Durvalumab (14 day) Indication • Stage 3 NSCLC after
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab-14day.pdf

Durvalumab(28day-1500mg)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (28 day – 1500mg) Regimen • NSCLC - Durvalumab (28 day – 1500mg) Indication • Durvalumab is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab28day-1500mg.pdf

Desensitisation home therapy programme - patient information

Description: This factsheet explains what exercises you can do at home to help with hand injuries as they heal.
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Desensitisation-home-therapy-programme-1813-PIL.pdf

Cataract in children - patient information

Description: We have given you this factsheet because your child has been diagnosed with a cataract.
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Cataract-in-children-1782-PIL.pdf

Apps to help your child

Description: Apps To Help Your Child The Oticon Companion app can be used with Oticon hearing aids and enables you or your child to a
Url: /Media/UHS-website-2019/Docs/Services/Child-health/Childrens-hearing/Apps-to-help-your-child.pdf

Innovation fund 202021

Description: Memo Chief Executive’s Office Trust Management Offices, MP 18 Southampton General Hospital Tremona Road Southampton SO16
Url: /Media/Southampton-Clinical-Research/Grants/Download/Innovation-fund-202021.pdf

Press release: Southampton's 'soft' laser therapy for cancer patients could be offered nationwide

Description: A 'soft' laser therapy pioneered in the UK by doctors in Southampton to help prevent side effects in patients receiving treatment
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/July-2018/Press-release-Southamptons-soft-laser-therapy-for-cancer-patients-could-be-offered-nationwide.aspx

Southampton's 'soft' laser therapy for cancer patients to be trialled nationwide

Description: A 'soft' laser therapy pioneered by doctors in Southampton to help prevent side effects in adult patients undergoing treatment for head
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/January-2018/Southamptons-soft-laser-therapy-for-cancer-patients-to-be-trialled-nationwide.aspx

Carboplatin Paclitaxel EC Pembrolizumab Neoadjuvant Ver1.0

Description: Chemotherapy Protocol BREAST CANCER PEMBROLIZUMAB WITH CARBOPLATIN/PACLITAXEL AND EC NEOADJUVANT BREAST CANCER FOLLOWED BY ADJUVANT PEMBROLIZUMAB Regimen • Breast-Pembrolizumab with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Paclitaxel-EC-Pembrolizumab-Neoadjuvant.pdf

Carboplatin(AUC6)-Paclitaxel-Pembrolizumab

Description: Chemotherapy Protocol LUNG CANCER CARBOPLATIN (AUC6)-PACLITAXEL-PEMBROLIZUMAB Regimen • Lung-Carboplatin (AUC6)-Paclitaxel-Pembrolizumab Indication - The patient has a histologically- or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinAUC6-Paclitaxel-Pembrolizumab.pdf

51 to 60 of 104

Previous … 4 5 6 7 8 … Next